Zoekresultaten - Portaal voor medische datamodellen (MDM-portaal)

Eligibility Brain Cancer NCT01065805

- 20-08-19 - 1 Formulier, 2 Itemgroepen, 13 Data-elementen, 1 Taal

Itemgroepen: Inclusion Criteria, Exclusion Criteria

A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01065805

Brain Metastases Stereotactic Radiosurgery or Whole-Brain Radiation NCT01372774 N107C - Randomization Form and Eligibility Checklist

- 14-07-17 - 1 Formulier, 3 Itemgroepen, 15 Data-elementen, 1 Taal

Itemgroepen: Eligibility Check, Registration Check, Stratification Factors

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery Cognitive/Functional Effects NCT01372774 Eligibility - N107C Randomization (Step 2) Form and Eligibility Checklist - 3226595v1.0 https://clinicaltrials.gov/ct2/show/NCT01372774

Eligibility DRKS00003778 NCT00749723 Recurrent Brain Tumors - Eligibility

- 20-09-21 - 1 Formulier, 1 Itemgroep, 25 Data-elementen, 2 Talen

Itemgroep: Inclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00749723

Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073 - Screening

- 13-10-20 - 1 Formulier, 24 Itemgroepen, 273 Data-elementen, 1 Taal

Itemgroepen: Date of visit, Assessment Date, Trial Screening, Enrollment, Clinical Trial Subject Unique Identifier, Demography, Eligibility Determination, Inclusion, Exclusion Criteria, disease characteristic, disease characteristic, Neoplasm Metastasis, Electrocardiography, Echocardiography; Multiple gated acquisition scanning, Laboratory Procedures, Central Laboratory; Laboratory Procedures, Local, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Hematology finding, Central Laboratory, Data, Disease, Operative Surgical Procedures, Disease, Relationships, Disease, Clinical Trials, Therapeutic procedures, Relationships, Disease, Cancer treatment, Prior Therapy, Neurologic Examination, Vital signs, Prior Radiation Therapy, Prior Radiation Therapy, Central Nervous System

Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases